Multilayer Transdermal Patch Membranes for Enhancer Retention
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Existing transdermal patch packaging materials fail to effectively prevent the absorption of skin permeation enhancers such as keto acids and sulfoxides, leading to significant loss during storage, which compromises the integrity and efficacy of the drug delivery system.
Innovation Solution
Employing a multilayered packaging film with specific polymer layers such as fluoropolymer, polypropylene, polyethylene terephthalate, low-density polyethylene, cyclic olefin copolymer, or polyacrylonitrile/methyl acrylate-acrylonitrile/butadiene graft copolymer to minimize the absorption of enhancers like levulinic acid, dimethyl sulfoxide, and other compounds, ensuring minimal absorption of less than 0.5% over extended storage periods.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If conventional packaging materials are used, then the packaging structure is simple and easy to manufacture, but the enhancers are absorbed by the polymer layers leading to loss of efficacy
Solution Approach 1:
The packaging film is divided into multiple distinct layers, each with specific functions: an outer layer for protection, an intermediate layer with moisture barrier properties, and an inner layer specifically designed to minimize enhancer absorption. This segmentation allows each layer to be optimized for its particular function, solving the contradiction between reliability and complexity.
Solution Approach 2:
The packaging employs a composite multilayered structure combining different polymer materials with complementary properties. The inner layer uses polymers with low affinity for enhancers, while intermediate layers provide moisture and oxygen barriers. This composite approach achieves high reliability in preventing enhancer loss while maintaining manufacturability through established lamination technologies.
2Duration of action of stationary object
If the storage period is extended to two years, then the shelf life is sufficient for commercial use, but the enhancers may be absorbed over time compromising drug delivery
Solution Approach 1:
The packaging film is pre-designed with an inner layer selected from polymers known to have minimal absorption of enhancers. This preliminary selection of materials with appropriate properties ensures that throughout the extended two-year storage period, the enhancers remain stable and are not absorbed, maintaining drug delivery reliability from manufacture through shelf life.
3Object-affected harmful factors
If polymers with high absorption capacity are used, then the packaging provides good protection, but the enhancers are absorbed into the polymer layers
Solution Approach 1:
Different regions of the packaging film have different properties tailored to local requirements. The inner layer in direct contact with the patch uses polymers with low enhancer absorption, while intermediate layers provide moisture and oxygen barriers, and the outer layer provides mechanical protection. This local optimization solves the contradiction between protection and substance loss.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The proposed packaging solution maintains the stability and efficacy of transdermal patches by significantly reducing enhancer absorption, preserving the drug and enhancer content for the intended shelf life, thereby ensuring consistent drug delivery.
Implementation Method 1
The absorption of drugs, enhancers and other excipients into the polymer layers of the packaging films is a much more difficult issue. Dissolution of these substances into polymers depends on their physical and other properties
Implementation Method 2
the package should protect the patch, the drug as well as the excipients, including skin permeation enhancers, from contamination, moisture, oxygen, sunlight and microbes
Implementation Method 3
the drug is delivered through the skin by diffusion through a thermodynamic gradient from the patch through the skin, the extracellular matrix and into the blood
Data Source
AI summary
Article side polymers useful in the packaging of transdermal patches are disclosed. These films do not absorb skin permeation enhancers that are contained in transdermal patches including keto acids such as levulinic acid or sulfoxides such as an alkyl sulfoxide, e.g., dimethyl sulfoxide. Using such polymeric film, multilayer pouch constructions can be manufactured which include other polymeric layers, such as aluminum foil for moisture and oxygen barrier properties, polyester for tear resistance and paper layers for optimal printing and design.